Germany
Japan
United Kingdom
China
KIR2DL2 Antibody - C-terminal region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Antibodies
View as table Download
Anti-KIR2DL2(lirilumab biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Target Symbol
- KIR2DL2